Inactive Instrument

Calendar ReShape Lifesciences Inc. Other OTC

Equities

RSLS

US7611236032

Chart calendar ReShape Lifesciences Inc.

42cd215b8d4c6059e32e2b5fe.mI7lV0F4RhH77EDa4q0kdTTWmf53pYDW7LOBw8vB6XA.0OunAAdPEXuzihSym-toO2Saq4Q8ybGwq-O0hqmN3UbqyrU8EzslIZOrGQ~1fa4b91b8883c2a8e6c3b8f6256d7492

Upcoming events on ReShape Lifesciences Inc.

11/08/2024 Q2 2024 Earnings Release (Projected)
06/11/2024 Q3 2024 Earnings Release (Projected)
30/03/2025 Q4 2024 Earnings Release (Projected)
19/05/2025 Q1 2025 Earnings Release (Projected)

Past events on ReShape Lifesciences Inc.

15/05/2024 21:30 Q1 2024 Earnings Call
15/05/2024 21:05 Q1 2024 Earnings Release
01/04/2024 21:30 Q4 2023 Earnings Call
01/04/2024 21:05 Q4 2023 Earnings Release
23/02/2024 16:30 Annual General Meeting
08/11/2023 22:00 Q3 2023 Earnings Call
08/11/2023 21:05 Q3 2023 Earnings Release
03/10/2023 23:30 LD Micro Main Conference
07/08/2023 22:00 Q2 2023 Earnings Call
07/08/2023 21:05 Q2 2023 Earnings Release
27/06/2023 17:00 American Society for Metabolic and Bariatric Surgery Meeting - Poster Number: A223
22/06/2023 16:00 OTC Life Science Investor Forum
20/06/2023 19:00 Maxim Group Virtual Healthcare Conference
15/05/2023 21:30 Q1 2023 Earnings Call
15/05/2023 21:05 Q1 2023 Earnings Release
04/05/2023 03:30 Keystone Conference - Poster Number: 2004
25/04/2023 21:30 Q4 2022 Earnings Call
25/04/2023 21:05 Q4 2022 Earnings Release
29/03/2023 18:00 Q2 Virtual Investor Summit
13/12/2022 Annual General Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


11,3
11,7
-3.43%
13,6
14,2
-4.35%
11,2
11,2
0.2%
8,68
8,90
-2.54%

9,99

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-12,5
-11,6
-7.39%
-27,7
-26,1
-6.34%
-46,4
-34,6
-33.89%
-15,4
-15,9
3.33%

-6,71

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-21,8
-16,3
-33.81%
-62,0
-31,6
-96.23%
-46,6
-34,7
-34.28%
-11,3
-12,1
6.24%

-6,65

Net income
Million USD
Released
Forecast
Spread
-74,2


-21,6
-16,2
-33.52%
-61,9
-31,7
-95.52%
-46,2
-34,8
-32.98%
-11,4
-12,1
5.97%

-6,65

EPS
USD
Released
Forecast
Spread
-2 147


-156
-117
-33.91%
-250
-145
-72.41%
-109
-85,0
-28.12%
-1,91
-3,84
50.26%

-0,45

Announcement Date30/04/2010/03/2128/03/2217/04/2301/04/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
2,44
3,22
-24.28%
2,89
3,41
-15.15%
2,80
3,62
-22.64%
3,11
3,10
0.23%
2,29
2,51
-8.99%
2,25
2,61
-13.64%
2,16
2,40
-10.21%
1,98
2,21
-10.24%
1,94
2,10
-7.6%

2,21


2,51


3,17

EBIT
Million USD
Released
Forecast
Spread
-8,40
-6,08
-38.08%
-9,38
-6,75
-38.89%
-11,9
-6,81
-75.12%
-16,6
-4,92
-238.57%
-5,63
-5,49
-2.66%
-3,98
-5,27
24.58%
-3,88
-4,03
3.65%
-1,90
-2,43
21.89%
-2,21
-2,18
-1.52%

-1,85


-1,53


-1,16

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-8,37
-6,15
-36.19%
-9,57
-6,75
-41.72%
-12,2
-6,70
-81.7%
-16,5
-4,60
-258.28%
-2,65
-5,64
53.08%
-3,49
-5,28
33.88%
-3,53
-4,02
12.12%
-1,67
-2,42
31.14%
-2,18
-2,16
-0.74%

-1,84


-1,51


-1,14

Net income
Million USD
Released
Forecast
Spread
-8,22
-6,15
-33.63%
-9,58
-6,75
-41.87%
-11,8
-6,80
-73.61%
-16,6
-4,90
-238.88%
-2,66
-5,64
52.83%
-3,49
-5,28
33.81%
-3,53
-4,02
12.05%
-1,70
-2,42
29.86%
-2,19
-2,16
-1.39%

-1,84


-1,51


-1,14

EPS
USD
Released
Forecast
Spread
-22,0
-17,3
-27.54%
-25,0
-18,0
-38.89%
-26,0
-17,8
-46.48%
-35,9
-10,0
-259%
-1,56
-4,21
62.95%
-1,08
-1,79
39.66%
-1,02
-1,20
15%

-0,18

-0,09
-0,16
43.75%

-0,12


-0,10


-0,07

Announcement Date23/05/2215/08/2214/11/2217/04/2315/05/2307/08/2308/11/2301/04/2415/05/24---
  1. Stock Market
  2. Equities
  3. RSLS Stock
  4. RSLS Stock
  5. Calendar ReShape Lifesciences Inc.